291 related articles for article (PubMed ID: 19597572)
1. Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.
Zhang C; Kim SK
Mar Drugs; 2009 Mar; 7(2):71-84. PubMed ID: 19597572
[TBL] [Abstract][Full Text] [Related]
2. Bioactives from Marine Organisms and their Potential Role as Matrix Metalloproteinase Inhibitors.
Thomas NV; Monica Diyya AS; Kim SK; Faraj KA; Ghafoor DD; Qian ZJ; Tigabu BM
Curr Pharm Des; 2022; 28(41):3351-3362. PubMed ID: 36411577
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.
Shi Y; Ma X; Fang G; Tian X; Ge C
NanoImpact; 2021 Jan; 21():100293. PubMed ID: 35559782
[TBL] [Abstract][Full Text] [Related]
4. Potential matrix metalloproteinase inhibitors from edible marine algae: a review.
Thomas NV; Manivasagan P; Kim SK
Environ Toxicol Pharmacol; 2014 May; 37(3):1090-100. PubMed ID: 24780533
[TBL] [Abstract][Full Text] [Related]
5. The past, present and future perspectives of matrix metalloproteinase inhibitors.
Li K; Tay FR; Yiu CKY
Pharmacol Ther; 2020 Mar; 207():107465. PubMed ID: 31863819
[TBL] [Abstract][Full Text] [Related]
6. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
7. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
Gentile E; Liuzzi GM
Drug Discov Today; 2017 Feb; 22(2):299-313. PubMed ID: 27697495
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinase inhibitors: status and scope from marine organisms.
Thomas NV; Kim SK
Biochem Res Int; 2010; 2010():845975. PubMed ID: 21197102
[TBL] [Abstract][Full Text] [Related]
9. Fucoidans from marine algae as potential matrix metalloproteinase inhibitors.
Thomas NV; Kim SK
Adv Food Nutr Res; 2014; 72():177-193. PubMed ID: 25081083
[TBL] [Abstract][Full Text] [Related]
10. Hydroxamic acids as matrix metalloproteinase inhibitors.
Verma RP
Exp Suppl; 2012; 103():137-76. PubMed ID: 22642192
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of matrix metalloproteinase inhibitors.
Tu G; Xu W; Huang H; Li S
Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs).
Li X; Wu JF
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):109-41. PubMed ID: 19951249
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase enzymes and their naturally derived inhibitors: novel targets in photocarcinoma therapy.
Gupta A; Kaur CD; Jangdey M; Saraf S
Ageing Res Rev; 2014 Jan; 13():65-74. PubMed ID: 24355347
[TBL] [Abstract][Full Text] [Related]
14. Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors.
Campestre C; Agamennone M; Tauro M; Tortorella P
Curr Drug Targets; 2015; 16(14):1634-44. PubMed ID: 25585125
[TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
Rangasamy L; Geronimo BD; OrtÃn I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
Pavlaki M; Zucker S
Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z
J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
19. Zymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors.
Ren Z; Chen J; Khalil RA
Methods Mol Biol; 2017; 1626():79-102. PubMed ID: 28608202
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
